Page 11 - Vertical Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Carlsmed Raises $10M to Commercialize Breakthrough aprevo™ Devices Today, Carlsmed, Inc. announces the close of a $10M Series A financing to commercialize the aprevo family of spine deformity correction devices. The San Diego-based medical device company is focused on improving outcomes for patients with adult spinal deformity. Carlsmed has pioneered a novel digital + surgical solution to create optimized surgical plans and personalized aprevo implants to enable superior correction of the spinal deformity. This round of financing is led by U.S. Venture Partners (USVP) and includes partic...

Carlsmed, Inc., a San Diego, CA-based medical device company, closed a $10M Series A financing round. The round was led by U.S. Venture Partners with participation from The Vertical Group, Cove Fund, and Wavemaker Three-Sixty Health, among others. The company intends to use the funds to commercialize its devices. Led by Mike Cordonnier, CEO, Carlsmed is the maker of the  aprevo family of spine deformity correction devices. Its novel digital + surgical solution creates optimized surgical plans and personalized implants to enable superior correction of the spinal deformity. In conjunction...

FAIRFIELD-SUISUN, CALIFORNIA San Diego’s Carlsmed corrals $10 million to bring personalized medicine to spine surgeries [The San Diego Union-Tribune] San Diego’s Carlsmed, which received regulatory approval last week for personalized implants used in complex spine surgeries, has raised $10 million in a Series A round of venture capital funding. The 10-employee startup will use the money to further commercialize its “aprevo” implants for adult degenerative scoliosis. The condition results in curvature of the spine that can lead to lower back and leg pain, among other things. It affects...

Print San Diego’s Carlsmed, which received regulatory clearance last week for personalized implants used in complex spine surgeries, has raised $10 million in a Series A round of venture capital funding. The 10-employee startup will use the money to further commercialize its “aprevo” implants for adult degenerative scoliosis. The condition results in curvature of the spine that can lead to lower back and leg pain, among other things. It affects about 6 million adults in the U.S. Carlsmed has developed patented, machine learning technology that takes patient imaging, prior outcomes data ...

socaltech.com San Diego-based Carlsmed, a biotech startup developing spine deformity correction devices, has raised $10M in a Series A funding. The funding was led by U.S. Venture Partners, and also included The Vertical Group, Cove Fund, and Wavemaker Three-Sixty Health, among others. According to the company, the funding will go to commercialize the company's family of aprevo spine deformity correction devices. The startup is led by CEO Mike Cordonnier. As part of the funding, it has added USVP's Jonathan Root, USVP's Phil Young, and Kevin Sidow, past CEO of St. Francis Medical Technologie...